Will an mRNA cancer vaccine receive regulatory approval for a cancer indication by 2030?

Market says 50% YES right now. Closes 31 Dec 2030.

Predict whether a personalized or shared-antigen mRNA cancer vaccine will receive formal regulatory approval for at least one cancer indication before 2031.

How this market resolves

YES requires approval from a recognized national medicines regulator for a defined cancer indication, not merely trial authorization.

Category: Tech & Science

Make your prediction on Tomorrow Market